Tracking Sensory Sensitivity Over the Migraine Cycle
Posted on February 29 2024,

A new exploratory study published in Cephalalgia analyzed how sensitivity to light, sound, touch, and smell changes over the course of a migraine cycle.
Researchers had 6 women with migraine track their headaches and sensory sensitivity over 27 straight days by completing daily questionnaires and sensitivity tests. The tests measured how bothered they were by things like noises, lights, brushing their skin, and sniffing odors like smoke and lavender.
The main finding was that on days when migraine headaches were more painful, patients reported more sensitivity to light, touch, and smoke smells compared to their days with less intense headaches.
However, unlike what was previously thought, the link between headaches and sound sensitivity relied on patients' anxiety levels due to the correlation being only seen on high anxiety days.
Also surprising was that over time, patients became more tolerant to bothersome lights. Earlier in the study, severe headaches meant reacting more to light, but, by the end, the opposite was true- even with severe headache pain. Oddly enough, lights bothered them less. It’s possible that the nervous system adapted to constant light exposure.
What does this mean for the underlying biology? The researchers believe that hypersensitivity patients with migraine experience with lights, sounds, touch, etc. stems from dysfunctional central processing centers in their brains that are supposed to filter and integrate all that sensory input. And this sensory integration problem seems embedded in migraine neurobiology itself rather than just being secondary to migraine attacks.
More studies are needed to confirm these results as this study only had 6 patients.
Thu, Apr 24, 25
Clinical Predictors for Efficacy of Erenumab (Aimovig) for Migraine
Discover key predictors of Aimovig (erenumab) response in migraine patients. This REFORM study reveals which patients benefit most from CGRP therapy and why timing matters. Evidence-based insights for better treatment...
Read MoreWed, Apr 23, 25
Effectiveness and Tolerability of Atogepant (Qulipta) in the Prevention of Migraine
STAR study shows atogepant (Qulipta) effectively reduces migraine days by 56.6% in real-world clinical practice, even for patients with previous treatment failures. Learn about this breakthrough.
Read MoreWed, Apr 23, 25
Impact of Visual Stimulus Complexity on Associative Learning in Migraine Patients
Groundbreaking research reveals how migraine patients process visual information differently. This 2025 study found that migraine patients take longer to process simple visual stimuli compared to complex images, which is...
Read More